Inactief instrument

Koers Ambit Biosciences Corp

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

Ambit Biosciences : Daiichi Sankyo and Ambit Announce Results of Tender Offer	11-11-14
Ambit Biosciences : Announces Expiration of Hart-Scott-Rodino Waiting Period	28-10-14
Ambit Biosciences : Announcement Regarding Submission of Tender Offer for Shares in Ambit Biosciences Corporation	14-10-14
Ambit Biosciences : Stockholders Encouraged to Contact Securities Law Firm about Takeover	01-10-14
Ambit Biosciences : Ryan & Maniskas, LLP : Announces Investigation of Ambit Biosciences Corporation	01-10-14

Managers	Titel	Leeftijd	Van
Ken Takeshita CEO	Chief Executive Officer	-	-

Besturend	Titel	Leeftijd	Van
Kenneth Joseph Keller BRD	Director/Board Member	61	10-11-14
Michael Martino CEO	Chief Executive Officer	68	16-11-11
Glenn Gormley BRD	Director/Board Member	-	10-11-14

Sector

	Vaira. 1 jan.	Kapi.
CSL LIMITED	-4,66%	86,13 mld.
SAMSUNG BIOLOGICS CO.,LTD.	+1,32%	39,82 mld.
BIOGEN INC.	-19,27%	30,42 mld.
UCB	+57,86%	25,23 mld.
BIOMARIN PHARMACEUTICAL INC.	-16,09%	15,35 mld.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,14%	11,95 mld.
INCYTE CORPORATION	-17,69%	11,6 mld.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,00%	11,51 mld.
SWEDISH ORPHAN BIOVITRUM AB	+5,24%	8,71 mld.